In mature B-cells, AID also causes off-target mutations in proto-oncogenes, thereby contributing to both initiation and progression of B-cell malignancies like chronic lymphocytic leukemia (CLL), Burkitt lymphoma and multiple myeloma (MM) [8–11]. Here, AICDA is linked to B-cell chronic lymphocytic leukemia.